Trading Signals: BAX Stock Price Prediction and Forecast (Mon. Dec. 1, 2014 - Wed. Sep. 27, 2023)(Baxter International Inc.)
| BAX latest price $83.4300 (-0.74%) ($83.0700 - $84.2200) on Mon. Dec. 30, 2019. | |
| | Trend Analysis and Forecast | | | Average Daily Percentage Swing | 1.63% (three month average) | RSI | 63 | Latest Price | $83.4300(-0.74%) | Stocks Behave Similarly | Similar Stock List | Daily Trend | BAX advances 0.2% a day on average for past five trading days. | Weekly Trend | BAX advances 0.8% a week on average for past two weeks. | Market Behavior | Broad based sell-off for large cap. Growth stock sell-off for small cap. | Correlated ETFs | Broad market will support BAX advance at 0% a week (0% probability) XLV(56%) SPLV(52%) XLP(52%) VYM(51%) DIA(48%) | Factors Impacting BAX price | BAX will decline at least -0.815% in a week (0% probabilities). VIXM(-30%) TLT(-20%) VXX(-11%) TIP(-4%) UUP(-3%) | Explanation | The rally is not sustainable and not supported by the broad market. | | | | | Relative Volatility | (options are extremely cheap) | | | Market Trend Strength | -0.815% (StdDev 1.63%) | Hourly BBV | -1.4 () | Intraday Trend | -0.8% | | | |
|
5 Day Moving Average | $84.2(-0.91%) | 10 Day Moving Average | $83.67(-0.29%) | 20 Day Moving Average | $83.13(0.36%) | To recent high | -5.7% | To recent low | 8.8% | Market Cap | $42.565b | | | | Baxter International, Inc. provides portfolio of essential renal and hospital products, including acute and chronic dialysis, sterile IV solutions, infusion systems and devices, parenteral nutrition therapies; premixed and oncolytic injectable, bio surgery products and anesthetics, drug reconstitution systems; and pharmacy automation, software and services. It operates through the following segment: Americas, Europe, Middle East & Africa and Asia-Pacific. The company was founded by Davis Baxter in 1931 and is headquartered in Deerfield, IL. |